GLP-1 Medicaid Coverage: Does Medicaid Cover Wegovy & Zepbound in 2026?

Quick answer: Does Medicaid cover GLP-1s?

Medicaid coverage for GLP-1 medications varies by state. Most states cover GLP-1s for type 2 diabetes (Ozempic, Mounjaro). Coverage for weight management (Wegovy, Zepbound) is less consistent — some states require prior authorization, step therapy, or documented participation in a weight management program. If Medicaid denies your GLP-1, alternatives include telehealth compounded semaglutide ($150-350/month) or patient assistance programs.

Medicaid GLP-1 coverage by category

Type 2 diabetes (Ozempic, Mounjaro)

Most state Medicaid programs cover GLP-1s for type 2 diabetes when prescribed by a Medicaid-enrolled provider. Prior authorization may be required, and some states require step therapy (trying metformin first).

Weight management (Wegovy, Zepbound)

Coverage for weight management is state-dependent. States with broader coverage typically require:

• BMI ≥ 30 (or ≥ 27 with comorbidities)
• Documented participation in a structured weight management program
• Prior authorization with medical records
• Step therapy (trying other weight loss medications first)

Compounded GLP-1s

Medicaid does not cover compounded medications. If you need compounded semaglutide, you'll need to pay out of pocket through a telehealth provider.

How to get GLP-1 approved through Medicaid

1. Visit a Medicaid-enrolled provider — your doctor must be enrolled in your state's Medicaid program
2. Document your BMI and conditions — record BMI ≥ 30, weight-related comorbidities, previous weight loss attempts
3. Complete step therapy if required — some states require trying metformin, phentermine, or lifestyle programs first
4. Submit prior authorization — your provider's office handles this with supporting medical records
5. Follow up — prior auth decisions typically take 3-7 business days
6. Appeal if denied — you have the right to appeal within 30-90 days depending on your state

See GLP-1 Prior Authorization Guide and Insurance Appeal Guide.

What to do if Medicaid denies GLP-1

• File an appeal — you have the right to appeal. Your provider can submit a letter of medical necessity
• Request a fair hearing — if the appeal is denied, request a state fair hearing
• Try telehealth compounded semaglutide — $150-350/month, no insurance required
• Check patient assistance programs — Novo Nordisk and Eli Lilly offer programs for uninsured/low-income patients. See Patient Assistance Programs
• Use GoodRx — modest savings at retail pharmacies. See GoodRx Guide

Medicaid vs Medicare GLP-1 coverage

• Medicaid — state-run, coverage varies by state, may cover weight management in some states
• Medicare — federal, Part D covers GLP-1s for diabetes, weight management coverage expanding. See Medicare Coverage 2026
• Manufacturer savings cards — not available for either Medicaid or Medicare patients

FAQ

Related articles

• GLP-1 Medicare Coverage 2026
• GLP-1 Prior Authorization
• GLP-1 Insurance Appeal
• Patient Assistance Program
• GLP-1 Cost Without Insurance
• Cheapest GLP-1 Options
• Medicare GLP-1 Bridge Program

Medical disclaimer: This content is for informational purposes only. Medicaid coverage varies by state and changes frequently. Contact your state Medicaid office for current details.